These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 693386)

  • 41. [Determination of calcium, oxalate and inhibitory activity of the urine in patients with calcium nephrolithiasis].
    Han KH; Cao LC; Ying YL
    Zhonghua Wai Ke Za Zhi; 1986 Mar; 24(3):173-5, 190. PubMed ID: 3757655
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of bendroflumethiazide on the renal handling of calcium, magnesium and phosphate in normocalcaemic renal stone formers and in hyperparathyroidism.
    Jorgensen FS; Transbol I
    Acta Med Scand; 1973 Oct; 194(4):327-34. PubMed ID: 4749172
    [No Abstract]   [Full Text] [Related]  

  • 43. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol.
    Levy FL; Adams-Huet B; Pak CY
    Am J Med; 1995 Jan; 98(1):50-9. PubMed ID: 7825619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Presence of trace elements in recurrent renal calculi].
    Nagy Z; szabó E
    Actas Urol Esp; 1977; 1(2):99-102. PubMed ID: 878940
    [No Abstract]   [Full Text] [Related]  

  • 45. [Metaphylaxis on the basis of outpatient metabolic tests in nephrolithiasis].
    Hiblbauer J; Base J; Zita K
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(3):379-84. PubMed ID: 3206213
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative effects of anticalculus management in the rat.
    Selikowitz SM; Olsson CA
    Invest Urol; 1976 Sep; 14(2):120-3. PubMed ID: 972003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Aborption of 47-Ca from digestive tract in patients with kidney calculi].
    Lorenz J; Hryńczuk B; Janukowicz-Lorenz H
    Pol Tyg Lek; 1973 Jun; 28(23):863-5. PubMed ID: 4720258
    [No Abstract]   [Full Text] [Related]  

  • 48. Urinary zinc excretion in recurrent calcareous nephrolithiasis (RCN) patients.
    Surian M; Graziani G; Colussi G; Antonacci A; Aroldi A; Giacchetti M; Masi F; Civati G; Minetti L
    Minerva Nefrol; 1979; 26(4):537-42. PubMed ID: 542223
    [No Abstract]   [Full Text] [Related]  

  • 49. [Active and recurrent kidney calculi. Metabolic findings and therapeutic consequences].
    Jorgensen H; Quist Paulsen A; Berstad A; Harbitz TB
    Tidsskr Nor Laegeforen; 1977 Oct; 97(30):1551-5. PubMed ID: 929531
    [No Abstract]   [Full Text] [Related]  

  • 50. [Evaluation of systemic magnesium reserves in patients with calcium-induced kidney calculi].
    Głuszek J
    Pol Arch Med Wewn; 1987 Sep; 78(3):130-8. PubMed ID: 3271292
    [No Abstract]   [Full Text] [Related]  

  • 51. Thiazide-induced rise in serum calcium and magnesium in patients on maintenance hemodialysis.
    Koppel MH; Massry SG; Shinaberger JH; Hartenbower DL; Coburn JW
    Ann Intern Med; 1970 Jun; 72(6):895-901. PubMed ID: 5448748
    [No Abstract]   [Full Text] [Related]  

  • 52. [Calcium metabolism disorders in kidney calculi patients].
    Berlin T; Collste L; von Garrelts B
    Lakartidningen; 1978 May; 75(19):1911-2. PubMed ID: 651449
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of calcium and phosphate metabolism in patients affected by essential hypertension and calcium nephrolithiasis.
    Malberti F; Surian M; Colussi G; Cosci P; Corradi B; Benazzi E; Minetti L
    Am J Nephrol; 1986; 6 Suppl 1():131-3. PubMed ID: 3826147
    [No Abstract]   [Full Text] [Related]  

  • 54. Immobilization: a cause of resorptive hypercalciuria.
    Jeantet A; Giachino G; Rossi P; Tetta C; Thea A; Squiccimarro G; Calitri V; Vercellone A
    Contrib Nephrol; 1984; 37():31-5. PubMed ID: 6713876
    [No Abstract]   [Full Text] [Related]  

  • 55. [Increased incidence of nephrolithiasis among lifeguards in Israel].
    Shabtai M; Malamud A; Berenheim J; Haimovitz C; Kedar SS; Better OS
    Harefuah; 1979 Aug; 97(3-4):57-9. PubMed ID: 540823
    [No Abstract]   [Full Text] [Related]  

  • 56. [Prevention effect of some substances on experimental oxalic calculosis in the frog].
    Sorrentino F; Fella A; Pota A
    Minerva Nefrol; 1979; 26(3):329-31. PubMed ID: 318058
    [No Abstract]   [Full Text] [Related]  

  • 57. Increased incidence of nephrolithiasis (N) in lifeguards (LG) in Israel.
    Better OS; Shabtai M; Kedar S; Melamud A; Berenheim J; Chaimovitz C
    Adv Exp Med Biol; 1980; 128():467-72. PubMed ID: 7424691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The role of saliva in the metabolism of magnesium and calcium].
    Gomershtein VA
    Stomatologiia (Mosk); 1971; 50(2):76-7. PubMed ID: 5291201
    [No Abstract]   [Full Text] [Related]  

  • 59. Re: Hydrochlorothiazide and Prevention of Kidney-stone Recurrence.
    Veser J
    Eur Urol; 2023 Aug; 84(2):242-243. PubMed ID: 37080895
    [No Abstract]   [Full Text] [Related]  

  • 60. Re: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence (NOSTONE).
    Chen DC; McVey A; Murphy DG; Eapen R; Lawrentschuk N
    Eur Urol; 2023 Sep; 84(3):353-354. PubMed ID: 37236856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.